The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback